SCHEMBL3720515

SCHEMBL3720515

CCC(P(C1CCCC1)C1CCCC1)P(C1CCCC1)C1CCCC1

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.39
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29065410 0.97 SHBG (0.37) SHBGCYP1A2
SCHEMBL115420 0.97 SHBG (0.42) SHBGCYP1A2
SCHEMBL17654213 0.95 SHBG (0.41) SHBGCYP1A2
SCHEMBL15658843 0.95 SHBG (0.33) SHBG
SCHEMBL17654211 0.89 SHBG (0.37) SHBGCYP1A2
SCHEMBL28247215 0.89 SHBG (0.37) SHBGCYP1A2
SCHEMBL3720695 0.80 SHBG (0.31) SHBGCYP1A2
SCHEMBL19463967 0.78 SHBG (0.34) SHBGCYP1A2
SCHEMBL1044303 0.78 SHBG (0.34) SHBGCYP1A2
SCHEMBL3170657 0.77 SHBG (0.37) SHBG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116693365-B Preparation method and preparation device system of hexafluorobutadiene 天津绿菱气体有限公司 2023-10-31 CN disclosed
CN-116693365-A Preparation method and preparation device system of hexafluorobutadiene 天津绿菱气体有限公司 2023-09-05 CN disclosed
EP-4121407-A1 Catalytic process for preparing an alpha, Beta-ethylenically unsaturated carboxylic acid salt BASF SE (DE) 2023-01-25 EP disclosed
WO-2021185879-A1 CATALYTIC PROCESS FOR PREPARING AN α,β-ETHYLENICALLY UNSATURATED CARBOXYLIC ACID SALT BASF SE (DE) 2021-09-23 WO disclosed
EP-3294701-A1 PROCESS FOR PREPARING AN UNSATURATED CARBOXYLIC ACID SALT BASF SE (DE) 2018-03-21 EP disclosed
EP-3142995-A1 PROCESS FOR PREPARING AN UNSATURATED CARBOXYLIC ACID SALT USING AN ARYLOXIDE BASF SE (DE) 2017-03-22 EP disclosed
EP-3142992-A1 PROCESS FOR PREPARING AN UNSATURATED CARBOXYLIC ACID SALT BASF SE (DE) 2017-03-22 EP disclosed
WO-2016180775-A1 PROCESS FOR PREPARING AN UNSATURATED CARBOXYLIC ACID SALT BASF SE (DE) 2016-11-17 WO disclosed
WO-2015173296-A1 PREPARING AN UNSATURATED CARBOXYLIC ACID SALT FROM AN ALKENE AND CARBON DIOXIDE USING A HETEROGENEOUS BASE BASF SE (DE) 2015-11-19 WO disclosed
WO-2015173277-A1 PROCESS FOR PREPARING AN UNSATURATED CARBOXYLIC ACID SALT USING AN ARYLOXIDE BASF SE (DE) 2015-11-19 WO disclosed
WO-2015173276-A1 PROCESS FOR PREPARING AN UNSATURATED CARBOXYLIC ACID SALT BASF SE (DE) 2015-11-19 WO disclosed
WO-2015173295-A1 PREPARING AN UNSATURATED CARBOXYLIC ACID SALT FROM AN ALKENE AND CARBON DIOXIDE USING A COVALENTLY IMMOBILIZED TRANSITION METAL COMPLEX BASF SE (DE) 2015-11-19 WO disclosed
EP-2435184-B1 PROCESS FOR PREPARING A COMPLEX JOHNSON MATTHEY PLC (GB) 2015-02-25 EP disclosed
US-8207364-B2 Process for preparing a complex JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2012-06-26 US disclosed
WO-2010136793-A1 PROCESS FOR PREPARING A COMPLEX JOHNSON MATTHEY PLC (GB) 2010-12-02 WO disclosed
US-20100305349-A1 PROCESS FOR PREPARING A COMPLEX JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2010-12-02 US disclosed
EP-1431302-B1 PROCESS FOR SYNTHESIS OF ORGANOMETALLIC COMPOUNDS SEKISUI CHEMICAL CO LTD (JP) 2009-03-18 EP disclosed
US-7098355-B2 Process for synthesis of organometallic compounds SEKISUI CHEMICAL CO., LTD. (JP) 2006-08-29 US disclosed
US-20060030723-A1 Process for synthesis of organometallic compounds SEKISUI CHEMICAL CO., LTD. (JP) 2006-02-09 US disclosed
EP-1431302-A1 PROCESS FOR SYNTHESIS OF ORGANOMETALLIC COMPOUNDS SEKISUI CHEMICAL CO., LTD. (JP) 2004-06-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030723-A1 Process for synthesis of organometallic compounds CYP4F12, CYP4F2, CYP4F11 SHBG 3581/4885CYP1A2 36/4885
US-20100305349-A1 PROCESS FOR PREPARING A COMPLEX EGFR, C9, C1R SHBG 3960/4885CYP1A2 866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.